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Background
Statins are currently the preferred agent for the treatment
of hypercholesterolemia. However, myalgia, increased
serum levels of creatinekinase (CK) and even rhabdomyo-
lysis may occur, characterizing the cholesterol - lowering
agents myopathy (CLAM), with a multifactorial aetiology.
In statin monotherapy, the incidence of CLAM is 0.1 to
0.5 % and is dose related. RYR1 (ryanodine 1) gene altera-
tion was observed in the patients with CLAM, an animal
model of MH (malignant hyperthermia) showed hyper
metabolism after simvastatin, simvastatin induced in vitro
contractures in muscle of animal model and susceptibility
to MH by IVCT (in vitro contracture test) was diagnosed
in patients with CLAM.
On the other way, postoperative rhabdomyolysis
occurred in patients treated with cholesterol-lowering
drugs, leading to the suggestion of suspend these medica-
tions prior to surgery or do not use succinylcholine in
patients taking these drugs . But this stance is challenged
by other groups. Thus, this study examined, in rats chroni-
cally exposed to simvastatin dose previously associated
with muscle alteration, the outcome of the IVCT.
Materials and methods
With approval of the local ethics committee, 30 male
Wistar rats of 8 weeks of age were divided into 3 groups:
A - control, B - Statin 5 mg/kg/day; C - Statin 20 mg/kg/
day. For two months , via intragastric intubations using
stainless curved feeding needle, the animals in groups B
and C received simvastatin daily, diluted with carboxy-
methyl cellulose (CMC) 0.5 %, group A received only
CMC. Next, the animals were anesthetized for removal of
the vastus lateralis muscles, used in the IVCT according
to the protocol of EMHG. The curves for each test were
analysed to determine if there were contractures.
Results
Two animals in the control group (0.3 +0.14 g), two ani-
mals in the 5mg statin group (0.2 ±0 g) and three animals
in the 20 mg statin group (0.22 ±0.02) had greater than
or equal to 0.2 g contracture in the presence of 2%
halothane. One animal in the 5mg statin group (0.28 g)
and two group of the 20 mg statin group (0.26 +0.02 g)
had greater than or equal to 0.2 g contracture in the pre-
sence of 2mM caffeine. But these contractures were mini-
mal and there was no statistical difference in the number
of animals per group with this change (chi-square, p not
significant).
Conclusions
A preliminary analysis of these findings suggests that
doses of 5-20 mg/kg of simvastatin were not sufficient
to cause contractures and do not increase the risk of
MH crisis in healthy individuals in monotherapy.
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